Tempus AI (NASDAQ:TEM) Stock Price Down 3.1% - What's Next?

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report)'s stock price traded down 3.1% on Monday . The company traded as low as $44.28 and last traded at $46.33. 3,093,174 shares changed hands during mid-day trading, a decline of 41% from the average session volume of 5,233,347 shares. The stock had previously closed at $47.83.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. Wolfe Research lowered shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Guggenheim restated a "buy" rating on shares of Tempus AI in a report on Tuesday, February 25th. Needham & Company LLC upped their price objective on shares of Tempus AI from $56.00 to $70.00 and gave the company a "buy" rating in a research note on Tuesday, February 25th. Bank of America lifted their target price on shares of Tempus AI from $54.00 to $60.00 and gave the company a "neutral" rating in a research note on Monday, March 3rd. Finally, Loop Capital dropped their price target on shares of Tempus AI from $57.00 to $52.00 and set a "buy" rating on the stock in a research note on Tuesday, January 14th. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, Tempus AI has an average rating of "Moderate Buy" and a consensus price target of $61.18.

Tempus AI Trading Down 7.5 %

The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The firm's fifty day moving average is $58.62 and its 200 day moving average is $51.55.

Insider Transactions at Tempus AI

In related news, major shareholder Bradley A. Keywell sold 170,720 shares of the business's stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $35.45, for a total transaction of $6,052,024.00. Following the transaction, the insider now owns 15,993,729 shares of the company's stock, valued at approximately $566,977,693.05. The trade was a 1.06 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Wayne A.I. Frederick sold 3,000 shares of the stock in a transaction on Monday, March 31st. The shares were sold at an average price of $45.54, for a total transaction of $136,620.00. Following the completion of the sale, the director now directly owns 26,514 shares of the company's stock, valued at approximately $1,207,447.56. This trade represents a 10.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,601,969 shares of company stock worth $317,330,782.

Institutional Investors Weigh In On Tempus AI

A number of institutional investors have recently added to or reduced their stakes in the company. ARK Investment Management LLC lifted its position in shares of Tempus AI by 132.1% in the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock worth $186,343,000 after acquiring an additional 3,141,487 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its position in Tempus AI by 166.0% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after purchasing an additional 2,021,394 shares during the period. Nikko Asset Management Americas Inc. boosted its stake in Tempus AI by 166.0% during the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Franklin Resources Inc. increased its holdings in Tempus AI by 240.5% in the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock valued at $93,251,000 after buying an additional 1,950,862 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in shares of Tempus AI by 86,947.2% in the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock valued at $55,836,000 after buying an additional 1,651,996 shares in the last quarter. 24.22% of the stock is owned by institutional investors and hedge funds.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.